Wall Street Journal Article on Pernix

[anonymous]

Reps have been saying this for some time now as reason why Trex is so hard to sell to doctors. Article paints Pernix in a very bad light. Will we now be investigated?

Thoughts please

 

[anonymous]

very negative article in WSJ today on how Pernix is price gouging its drugs and why doctors are not prescribing (too costly - other generic alternatives)

 

[anonymous]

Reps have been saying this for some time now as reason why Trex is so hard to sell to doctors. Article paints Pernix in a very bad light. Will we now be investigated?

Thoughts please

 

[anonymous]

It was a poorly written article and picked the wrong drug to use as an example of price gouging. 1 - there are other alternatives available and 2 - Pernix offers HEAVY discounts if you go direct and the spokesperson for Pernix even said "if the customer calls direct, they can get the prescription pack filled at $20". Pernix is no KBIO, where KBIO had the only solution for some and they forced price hikes because they were the only drug available. That's wrong. WSJ made a poor decision on who they targeted.

 

[anonymous]

You sound like an investor. This is a sales rep board and honestly everything the WSJ article mentioned is true and something we have known in the field for some time now. One of the reason why we are not and will not be making our sales revenue numbers the rest of this year. Mgmt is not listening to us as to why we cannot sell.